In vitro Enzyme Inhibition and In vivo Anti-hyperuricemic Potential of Malic Acid: An Experimental Approach

References

• Vijeesh, V., Vysakh, A., Jisha, N., Latha, M.S. (2022). Multispectroscopic Binding Studies and in Silico Docking Analysis of Interactions of Malic Acid with Xanthine Oxidase. J. Mol. Struct. 133621.
   Google Scholar
• Gao, Z., Zuo, M., Han, F., Yuan, X., Sun, M., Li, X., Liu, R., Jiang, W., Zhang, L., Chang, B., Yang, J. (2019). Renal Impairment Markers in Type 2 Diabetes Patients with Different Types of Hyperuricemia. J. Diabetes Investig. 10(1): 118-123. doi: 10.1111/jdi.12850
   PubMed Web of Science ®Google Scholar
• Vijeesh, V., Vysakh, A., Jisha, N., Latha, M.S. (2021). In Vitro Enzyme Inhibition and in vivo Anti-Hyperuricemic Potential of Eugenol: An Experimental Approach. Drug Dev. Ind. Pharm. 47(12): 1998-2003. doi: 10.1080/03639045.2022.2083156
   PubMed Web of Science ®Google Scholar
• Desideri, G., Castaldo, G., Lombardi, A., Mussap, M., Testa, A., Pontremoli, R., Punzi, L., Borghi, C. (2014). Is It Time to Revise the Normal Range of Serum Uric Acid Levels? Eur. Rev. Med. Pharmacol. Sci. 18(9): 1295-1306.
   PubMed Web of Science ®Google Scholar
• Watanabe, S., Kawano, T., Horino, T., Matsumoto, T., Nagata, K., Hatakeyama, Y., Locatelli, F.M., Yokoyama, M., Terada, Y., Okuhara, Y. (2019). Influence of Hyperuricemia Treatment on Postoperative Acute Kidney Injury among Hyperuricemia Patients: A Single-Center Retrospective Database Analysis. BMC Res. Notes. 12(1): 756. doi: 10.1186/s13104-019-4783-1
   PubMed Web of Science ®Google Scholar
• Rahmani, B., Patel, S., Seyam, O., Gandhi, J., Reid, I., Smith, N., Khan, S.A. (2019). Current Understanding of Tumor Lysis Syndrome. Hematol. Oncol. 37(5): 537-547. doi: 10.1002/hon.2668
   PubMed Web of Science ®Google Scholar
• Kaneko, K., Aoyagi, Y., Fukuuchi, T., Inazawa, K., Yamaoka, N. (2014). Total Purine and Purine Base Content of Common Foodstuffs for Facilitating Nutritional Therapy for Gout and Hyperuricemia. Biological and Pharmaceutical Bulletin. 709-721. doi: 10.1248/bpb.b13-00967
   PubMed Web of Science ®Google Scholar
• King, C., Lanaspa, M.A., Jensen, T., Tolan, D.R., Sánchez-Lozada, L.G., Johnson, R. J. (2018). Uric Acid as a Cause of the Metabolic Syndrome. In Contributions to Nephrology. 192: 88-102. doi: 10.1159/000484283
   PubMed Web of Science ®Google Scholar
• Bjornstad, P., Lanaspa, M.A., Ishimoto, T., Kosugi, T., Kume, S., Jalal, D., Maahs, D.M., Snell-Bergeon, J.K., Johnson, R.J., Nakagawa, T. (2015). Fructose and Uric Acid in Diabetic Nephropathy. Diabetologia. 58(9): 1993-2002. doi: 10.1007/s00125-015-3650-4
   PubMed Web of Science ®Google Scholar
• Choi, Y.J., Shin, H.S., Choi, H.S., Park, J.W., Jo, I., Oh, E.S., Lee, K.Y., Lee, B.H., Johnson, R.J., Kang, D.H. (2014). Uric Acid Induces Fat Accumulation via Generation of Endoplasmic Reticulum Stress and SREBP-1c Activation in Hepatocytes. Lab. Investig. 94(10): 1114-1125. doi: 10.1038/labinvest.2014.98
   PubMed Web of Science ®Google Scholar
• Liu, L., Zhang, L., Ren, L., Xie, Y. (2020). Advances in Structures Required of Polyphenols for Xanthine Oxidase Inhibition. Food Front. 1(2): 152-167. doi: 10.1002/fft2.27
   Google Scholar
• Pacher, P., Nivorozhkin, A., Szabo, C. (2006). Therapeutic Effects of Xanthine Oxidase Inhibitors: Hum. Physiol. 58(1): 87-114.
   Google Scholar
• Tiptiri-Kourpeti, A., Fitsiou, E., Spyridopoulou, K., Vasileiadis, S., Iliopoulos, C., Galanis, A., Vekiari, S., Pappa, A., Chlichlia, K. (2019). Evaluation of Antioxidant and Antiproliferative Properties of Cornus Mas L. Fruit Juice. Antioxidants. 8(9): 377. doi: 10.3390/antiox8090377
   Web of Science ®Google Scholar
• Tang, X., Liu, J., Dong, W., Li, P., Li, L., Lin, C., Zheng, Y., Hou, J., Li, D. (2013). The Cardioprotective Effects of Citric Acid and L-Malic Acid on Myocardial Ischemia/ Reperfusion Injury. Evidence-based Complement. Altern. Med. 2013: 1-11.
   Web of Science ®Google Scholar
• Zhang, Q.C., Zhao, Y., Bian, H.M. (2013). Antiplatelet Activity of a Novel Formula Composed of Malic Acid, Succinic Acid and Citric Acid from Cornus Officinalis Fruit. Phyther. Res. 27(12): 1894-1896. doi: 10.1002/ptr.4934
   PubMed Web of Science ®Google Scholar
• Izquierdo-Vega, J.A., Arteaga-Badillo, D.A., Sánchez-Gutiérrez, M., Morales-González, J.A., Vargas-Mendoza, N., Gómez-Aldapa, C.A., Castro-Rosas, J., Delgado-Olivares, L., Madrigal-Bujaidar, E., Madrigal-Santillán, E. (2020). Organic Acids from Roselle (Hibiscus Sabdariffa L.)-A Brief Review of Its Pharmacological Effects. Biomedicines. 8(5): 100. doi: 10.3390/biomedicines8050100
   PubMed Web of Science ®Google Scholar
• Wei, Z., Xu, Y., Xu, Q., Cao, W., Huang, H., Liu, H. (2021). Microbial Biosynthesis of L-Malic Acid and Related Metabolic Engineering Strategies: Advances and Prospects. Frontiers in Bioengineering and Biotechnology. 2021.
   Google Scholar
• Rodgers, A.L., Webber, D., De Charmoy, R., Jackson, G.E., Ravenscroft, N. (2014). Malic Acid Supplementation Increases Urinary Citrate Excretion and Urinary Ph: Implications for the Potential Treatment of Calcium Oxalate Stone Disease. J. Endourol. 28(2): 229-236. doi: 10.1089/end.2013.0477
   PubMed Web of Science ®Google Scholar
• Vijeesh, V., Jisha, N., Vysakh, A., Latha, M.S. (2021). Spectrochimica Acta Part A : Molecular and Biomolecular Spectroscopy Interaction of Eugenol with Xanthine Oxidase: Multi Spectroscopic and in Silico Modelling Approach. Spectrochim. Acta Part A Mol. Biomol. Spectrosc. 258: 119843. doi: 10.1016/j.saa.2021.119843
   PubMedGoogle Scholar
• Lin, S., Zhang, G., Pan, J., Gong, D. (2015). Deciphering the Inhibitory Mechanism of Genistein on Xanthine Oxidase in Vitro. J. Photochem. Photobiol. B Biol. 153: 463-472. doi: 10.1016/j.jphotobiol.2015.10.022
   PubMed Web of Science ®Google Scholar
• Vijeesh, V., Vysakh, A., Jisha, N., Latha, M.S. (2022). Malic Acid Attenuates Potassium Oxonate Induced Gouty Inflammation in Wistar Rat. Biointerface Res. Appl. Chem. 12(2): 1682-1691.
   Web of Science ®Google Scholar
• Cicero, A.F.G., Fogacci, F., Kuwabara, M., Borghi, C. (2021). Therapeutic Strategies for the Treatment of Chronic Hyperuricemia: An Evidence-Based Update. Medicina (B. Aires). 57(1): 58. doi: 10.3390/medicina57010058
   Google Scholar
• Zafar, H., Hayat, M., Saied, S., Khan, M., Salar, U., Malik, R., Choudhary, M.I., Khan, K.M. (2017). Xanthine Oxidase Inhibitory Activity of Nicotino/Isonicotinohydrazides: A Systematic Approach from in Vitro, in Silico to in Vivo Studies. Bioorganic Med. Chem. 25(8): 2351-2371. doi: 10.1016/j.bmc.2017.02.044
   PubMed Web of Science ®Google Scholar
• Lin, S., Zhang, G., Liao, Y., Pan, J. (2015). International Journal of Biological Macromolecules Inhibition of Chrysin on Xanthine Oxidase Activity and Its Inhibition Mechanism. Int. J. Biol. Macromol. 81: 274–282. doi: 10.1016/j.ijbiomac.2015.08.017
   PubMed Web of Science ®Google Scholar
• Zhou, Q.M., Zhao, X.Y., Wang, H.G., Yang, H.G., Song, J.K., Wang, J.H., Du, G.H. (2018). Mechanism and Uric Acid Reducing Effects of Theaflavin on Potassium Oxonate-Induced Hyperuricemia in Mice. Chinese J. New Drugs. 27(14): 1631-1638.
   Google Scholar
• Spiga, R., Marini, M.A., Mancuso, E., Di Fatta, C., Fuoco, A., Perticone, F., Andreozzi, F., Mannino, G.C., Sesti, G. (2017). Uric Acid Is Associated with Inflammatory Biomarkers and Induces Inflammation Via Activating the NF-ΚB Signaling Pathway in HepG2 Cells. Arterioscler. Thromb. Vasc. Biol. 37(6): 1241-1249. doi: 10.1161/ATVBAHA.117.309128
   PubMed Web of Science ®Google Scholar
• Liu, J., Shen, P., Ma, X., Yu, X., Ni, L., Hao, X., Wang, W., Chen, N. (2019). White Blood Cell Count and the Incidence of Hyperuricemia: Insights from a Community-Based Study. Front. Med. 13(6): 741-746. doi: 10.1007/s11684-017-0579-7
   PubMed Web of Science ®Google Scholar
• Su, P., Hong, L., Zhao, Y., Sun, H., Li, L. (2014). The Association Between Hyperuricemia and Hematological Indicators in a Chinese Adult Population. Medicine (Baltimore). 95(7): e2822. doi: 10.1097/MD.0000000000002822
   Web of Science ®Google Scholar